Pharmacological evaluation of hyperin for antihyperglycemic activity and effect on lipid profile in diabetic rats.
Antihyperglycemic potential of hyperin at 25 and 50 mg/kg doses for 30 days to streptozotocin induced diabetic rats has been reported. In oral glucose tolerance test, hyperin treated rats showed a significant reduction in blood glucose level after 120 min..... Read More